Detect of chromosal abnormalities. ??????? ????????? ? ????????
Conditions
Interventions
Intervention 1: 20 gauge needle will be used for Amniocentesis in group 1. Intervention 2: 22 gauge needle will be used for Amniocentesis in group 2.
Diagnosis
20 gauge needle will be used for Amniocentesis in group 1
22 gauge needle will be used for Amniocentesis in group 2
Sponsors
Vice chancellor for Research
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: single pregnancy;no history of cervical classic failure,hereditary or non-hereditary coagulation disorders, myoma,major fetal anomalies. Exclusion criterion: withdrew from continuing the research
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intencity. Timepoint: During amniocentesis. Method of measurement: VAS (Visual Analog Scale) system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Abortion under 22 weeks. Timepoint: Up to a week after amniocentesis. Method of measurement: During the phone call.The symptoms of bleeding and pain and miscarriage.;Vaginal bleeding. Timepoint: Up to a week after amniocentesis. Method of measurement: 1-Less than menstrual bleeding 2-menstrual bleedingl.3- more than menstrual bleeding.;Continuous leakage of amniotic fluid. Timepoint: After 6 hours of amniocentesis to 1 week after the procedure. Method of measurement: Observation, ultrasound , nitrazine test.;Chorioamnionitis. Timepoint: Until a week after the procedure. Method of measurement: Uterine tenderness and maternal fever greater than 38°C.;Uterine cramps. Timepoint: After 6 hours of amniocentesis to 1 week after the procedure. Method of measurement: Uterine contractions felt by the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBarband Sharare
Tabriz University of Medical Sciences
Outcome results
None listed